1. Scandinavian Simvastatin Survival Study Group (1994) Randomized Trial of Cholesterol-Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S),Lancet 344, 1863–1869.
2. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKilop, J.H., and Packard, C.C. (1995) Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia,N. Engl. J. Med. 20, 1301–1307.
3. Sacks, F.M., Pfeiffer, M.D., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, J.M.O., Wun, C.-C., Davis, B.R., and Braunwald, E. (1996) The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels,N. Engl. J. Med. 334, 1001–1009.
4. Simes, R.J., Watson, J., Anderson, N., Hankey, G., Simes, S., and Tonkin, A. (1998) Pravastatin Reduces Total Mortality in Patients with Coronary Heart Disease and Average Cholesterol Levels: Relationship of Baseline Cholesterol and Treatment Effect in the LIPID Trial,J. Am. Coll. Cardiac (Abstr.) 31, 1116–1124.
5. Gould, A.L., Rossouw, J.E., Santanello, N.C., Heyse, J.F., and Furberg, C.D. (1998) Cholesterol Reduction Yields Clinical Benefit,Circulation 97, 946–952.